Verastem | VSTM - Ebitda

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $-21.3M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
AstraZeneca USD 5.23B 272M Sep/2025
Curis USD -12.3M 231K Sep/2023
Cytokinetics USD -107.82M 45.51M Jun/2025
Gilead Sciences USD 4.03B 628M Sep/2025
Incyte USD 506.92M 74.6M Sep/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Novartis USD 5.88B 290M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 37.7M 25.41M Jun/2025